Data gathered: June 7
Alternative Data for Becton Dickinson and Co
About Becton Dickinson and Co
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
| Price | $173.45 |
| Target Price | Sign up |
| Volume | 2,040,000 |
| Market Cap | $49B |
| Year Range | $165.15 - $247.95 |
| Dividend Yield | 2.43% |
| PE Ratio | 33.08 |
| Analyst Rating | 83% buy |
| Industry | Medical Devices |
In the news
Targeted Drug Delivery Research Business Analysis Report 2024-2030 with Focus on 30+ Key Players Such as AbbVie, Amgen, AstraZeneca, Becton Dickinson and Co, & Bristol-Myers SquibbMay 28 - GlobeNewswire |
|
Citigroup Downgrades Becton, Dickinson and (BDX)May 21 - Fintel |
|
 |
BDX Q1 Earnings Call: Missed Revenue Expectations, Margin Expansion, and Strategic U.S. InvestmentsMay 14 - Yahoo |
|
Becton Dickinson (NYSE:BDX) Unveils Advanced Cell Analyzer With Spectral And Imaging InnovationsMay 14 - Yahoo |
 |
Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript)May 13 - SeekingAlpha |
|
The Strong Earnings Posted By Becton Dickinson (NYSE:BDX) Are A Good Indication Of The Strength Of The BusinessMay 8 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 5.27B | 3.02B | 2.26B | 308M | 546M | 3.350 |
| Q4 '24 | 5.17B | 2.93B | 2.24B | 303M | 1.07B | 3.430 |
| Q3 '24 | 5.44B | 2.95B | 2.49B | 400M | 697M | 3.810 |
| Q2 '24 | 4.99B | 2.68B | 2.31B | 487M | 1.21B | 3.500 |
| Q1 '24 | 5.05B | 2.74B | 2.3B | 537M | 1.33B | 3.170 |
Insider Transactions View All
| Shan David filed to sell 4,575 shares at $171.2. June 2 '25 |
| Garrison Michael David filed to sell 4,887 shares at $197.3. April 10 '25 |
| Byrd Richard filed to sell 6,952 shares at $230. March 19 '25 |
| Byrd Richard filed to sell 7,411 shares at $224.9. March 13 '25 |
| SCOTT BERTRAM L filed to sell 36,033 shares at $228. February 12 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$102.09 0% | 44 |
 |
Edwards LifesciencesEW |
$77.52 0% | 40 |
 |
Intuitive SurgicalISRG |
$557.08 0% | 61 |
 |
MedtronicMDT |
$87.44 0% | 45 |
 |
StrykerSYK |
$383.89 0% | 46 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rob Bresnahan |
Apr 29, 25 | Sell | $1K - $15K |
| Jefferson Shreve |
Apr 14, 25 | Sell | $15K - $50K |
| Ro Khanna |
Oct 8, 24 | Sell | $1K - $15K |
Read more about Becton Dickinson and Co (BDX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Becton Dickinson and Co?
The Market Cap of Becton Dickinson and Co is $49B.
What is Becton Dickinson and Co's PE Ratio?
As of today, Becton Dickinson and Co's PE (Price to Earnings) ratio is 33.08.
What is the current stock price of Becton Dickinson and Co?
Currently, the price of one share of Becton Dickinson and Co stock is $173.45.
How can I analyze the BDX stock price chart for investment decisions?
The BDX stock price chart above provides a comprehensive visual representation of Becton Dickinson and Co's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Becton Dickinson and Co shares. Our platform offers an up-to-date BDX stock price chart, along with technical data analysis and alternative data insights.
Does BDX offer dividends to its shareholders?
Yes, Becton Dickinson and Co (BDX) offers dividends to its shareholders, with a dividend yield of 2.43%. This dividend yield represents Becton Dickinson and Co's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Becton Dickinson and Co in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Becton Dickinson and Co?
Some of the similar stocks of Becton Dickinson and Co are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.